Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of immune cell and its preparation method and application

A technology of immune cells and cells, applied in the field of cell biology, can solve the problems of low efficiency of malignant tumors and low effective ratio of therapy, and achieve the effect of overcoming the low effective ratio

Active Publication Date: 2019-10-25
BEIJING TAIDONG BIOTECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to overcome the inefficiency of traditional methods for treating malignant tumors and the defects of the low effective ratio of immune checkpoint inhibitor therapy, and provide an immune cell with the function of treating malignant solid tumors and its application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of immune cell and its preparation method and application
  • A kind of immune cell and its preparation method and application
  • A kind of immune cell and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] 1. Mice and cell lines

[0068] C57BL / 6J (H-2Kb) mice were purchased from Shanghai Experimental Animal Center, Numb f / f 、Numblike f / f 、Numb&Numblike f / f Mice were donated by Professor Li Huashun of Tongji University School of Medicine, and CD11c-cre mice were purchased from Shanghai Nanfang Model Company. will Numb f / f 、Numblike f / f 、Numb&Numblike f / f The mice were crossed with CD11c-cre mice to obtain Numb KO 、Numblike KO 、Numb&Numblike KO DC mice and their respective littermate control mice Numb f / f 、Numblike f / f 、Numb&Numblike f / f . Schematic such as figure 1 shown.

[0069] 1.1 Laser confocal observation of the subcellular localization of Numb molecules

[0070] Isolate and culture mouse spleen dendritic cells, add LPS (1μl / ml) to stimulate, collect cells at designated time points, take cell pellet after centrifugation, resuspend in 100μl PBS, label with anti-mouse FITC-CD11c fluorescent antibody for 15min, PBS Wash 3 times. Fix with 2% paraformalde...

Embodiment 2

[0096] 1. Antigen-loaded DC-CTL cells

[0097] 1.1 Melanoma cell culture and antigen preparation

[0098] Melanoma cells B16F10 were cultured in DMEM medium (containing 10% FBS) at 37°C, 5% CO 2In the incubator, subculture every 2-3 days, collect the B16F10 cells in the logarithmic growth phase, and use sterile saline to adjust the cell concentration to 2×10 7 / ml, freeze-thawed three times with liquid nitrogen, and filtered at 0.45 μm to obtain the whole tumor antigen for future use.

[0099] 1.2 DC antigen loading

[0100] Adjust the cell density of the above-mentioned Numb / Numblike knockout DC cells to 1×10 6 / ml, tumor cell antigen (DC:tumor cell=1:10, number ratio) was added, and only culture medium was added to the control group. At 37°C, 5% CO 2 Incubate for 48 hours under the same conditions, add 10 μg / ml TNF-α, continue to culture for 48 hours, collect cells and supernatant for use.

[0101] 1.3 Antigen-loaded DCs induce CTL cells

[0102] The spleen cell suspe...

Embodiment 3

[0114] Construction of mouse subcutaneous melanoma model and cell therapy

[0115] Collect the B16F10 cells in the logarithmic growth phase and resuspend them with an appropriate amount of PBS to make the density 1×10 7 cells / mL.

[0116] Take 100 μL of cell suspension and inoculate C57 mice. On the 5th day after inoculation of B16F10 cells, tumor-bearing mice were injected with 1×10 6 A spleen-derived DC or bone marrow-derived DC and control DC were also set up as a negative control group injected with PBS. Mice were sacrificed on day 27 after inoculation with B16F10, and subsequent experimental analysis was performed, including tumor weight measurement and tumor infiltrating lymphocyte content detection. The result is as Figure 14 and 15 shown.

[0117] Figure 14 Among them, dendritic cells knocked out of Numb and Numblike proteins can effectively inhibit tumor growth.

[0118] Figure 15 Among them, the content of tumor-infiltrating lymphocytes increased in mice ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of cell biology, and in particular to an immune cell and a preparation method and applications thereof. Numb protein and / or Numb-like proteins in the immunecell have no expression or low expression. Numb and Numb-like are homologous genes, and the two genes in tumors are subjected to a plurality of researches. Current studies show that the two genes areoncogenes or tumor suppressor genes in cancer cells, but the role of the two genes in immune cells is rarely researched in the prior art. The present inventor finds that the deletion of the Numb and Num-blike genes in immune cells can enhance the function of the immune cells, and can enhance the anti-tumor immune response especially for dendritic cells.

Description

technical field [0001] The present invention relates to the field of cell biology, in particular to an immune cell and its preparation method and application. Background technique [0002] Tumor has always been a major disease that plagues the world and seriously endangers human health. Therefore, it is an important research topic in the world medical community to find an effective tumor treatment method and completely conquer the tumor. At present, the traditional three main treatment methods are surgery, chemotherapy, and radiotherapy. Although these three main treatment methods are the basic means of global tumor treatment, their therapeutic effects are very limited. Recently, tumor immunotherapy is emerging all over the world, bringing hope to cancer patients. At present, the cells used in tumor immunotherapy are mainly monocytes, T cells or dendritic cells or immune cell inhibitory molecular blockers, such as T cells or monocytes activated by the lymphokine IL-2; or ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867A61K35/17A61K35/15A61K45/06A61P35/00
CPCA61K35/15A61K35/17A61K45/06A61P35/00C12N5/0636C12N5/0639C12N5/0642C12N5/0645C12N5/0646C12N15/86C12N2510/00C12N2740/15043A61K2300/00
Inventor 李兵
Owner BEIJING TAIDONG BIOTECH CO LTD